A vaccine against the delta COVID-19 variant is being developed
Pfizer and BioNTech are working together to develop a new vaccine against COVID-19.
Pharmaceutical companies have issued such an official statement. The new drug is designed to combat the delta strain of coronavirus, which is spread in about 100 countries around the world.
The third injection of the current two-component vaccine “provides the highest level of protection against all known variants of COVID-19, including the delta variant,” the statement said. However, the scientists noted that they are “developing an updated version of the drug.”
According to the latest data from the Israeli Ministry of Healthcare, the effectiveness of the vaccine has decreased six months after vaccination against coronavirus. The delta version of the virus is prevalent in this country.
With the permission of the authorities, clinical trials of the new vaccine may begin in early August. Earlier, US health regulators rejected Pfizer and BioNTech's offer of additional coronavirus vaccinations.
Новостной портал – ATPress